Drugs / NPC-22
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04503863 | Jul → Nov 2020 | — | Nobelpharma | Completed | No outcome recorded |
| Phase 1 | NCT04203862 | Nov 2019 → Feb 2020 | — | Nobelpharma | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NPC-22 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04503863 ↗ |